Myasthenia Gravis: a plain-language guide built from published research

Please read this first. This guide is a companion to your medical team, not a replacement, and it is not medical advice. Everything here is tied to published research. If something you expected is not here, it almost always means we have not mapped a source for it yet, not that it is unknown to medicine. Myasthenia Gravis is an early, growing map, so it will look incomplete on purpose: we would rather show less and have every line be something you can check than fill the page with claims we cannot stand behind. For anything about your own situation, your clinicians hold the full picture. How this guide is built and why.

What it is

Myasthenia gravis is an autoimmune disorder of the junction between nerve and muscle, marked by muscle weakness that fluctuates, getting worse and better at different times.

Signs and symptoms

Dysarthria

Dysarthria means slurred or unclear speech, which can happen when the muscles used for speaking weaken in MG.

Limited evidenceSource: ORPHA:589

Evidence ratingweak

Study designontology_import

Confidence (0-1)0.7

Replicationunreplicated

Supporting sourcesPMID:41338982

Notesplain_language confirmed from PMID:41338982 via curation 2026-06-11.

Last reviewed2026-06-11

Abnormal thymus morphology

The thymus gland is often abnormal in MG. These thymus changes, including tumors called thymomas, are more common in generalized MG.

Limited evidenceSource: ORPHA:589

Evidence ratingweak

Study designontology_import

Confidence (0-1)0.7

Replicationunreplicated

Supporting sourcesPMID:42048329

Notesplain_language confirmed from PMID:42048329 via curation 2026-06-11.

Last reviewed2026-06-11

Dyspnea

Dyspnea means shortness of breath. In MG it can occur when the breathing muscles weaken.

Limited evidenceSource: ORPHA:589

Evidence ratingweak

Study designontology_import

Confidence (0-1)0.7

Replicationunreplicated

Supporting sourcesPMID:42064058

Notesplain_language confirmed from PMID:42064058 via curation 2026-06-11.

Last reviewed2026-06-11

Respiratory failure

In severe MG flares (myasthenic crisis), the breathing muscles can fail. This is a medical emergency that needs breathing support.

Limited evidenceSource: ORPHA:589

Evidence ratingweak

Study designontology_import

Confidence (0-1)0.7

Replicationunreplicated

Supporting sourcesPMID:41680628

Notesplain_language confirmed from PMID:41680628 via curation 2026-06-11.

Last reviewed2026-06-11

Thymoma

Some people with MG have a tumor of the thymus gland called a thymoma, and the thymus is often abnormal in MG.

Limited evidenceSource: ORPHA:589

Evidence ratingweak

Study designontology_import

Confidence (0-1)0.7

Replicationunreplicated

Supporting sourcesPMID:42048329

Notesplain_language confirmed from PMID:42048329 via curation 2026-06-11.

Last reviewed2026-06-11

Ptosis

Ptosis means drooping of one or both eyelids. It is one of the most common early signs of MG.

Limited evidenceSource: ORPHA:589

Evidence ratingweak

Study designontology_import

Confidence (0-1)0.7

Replicationunreplicated

Supporting sourcesPMID:41940097

Notesplain_language confirmed from PMID:41940097 via curation 2026-06-11.

Last reviewed2026-06-11

Diplopia

Diplopia means double vision, from weakness of the eye muscles. It is a frequent early symptom of MG.

Limited evidenceSource: ORPHA:589

Evidence ratingweak

Study designontology_import

Confidence (0-1)0.7

Replicationunreplicated

Supporting sourcesPMID:42048329

Notesplain_language confirmed from PMID:42048329 via curation 2026-06-11.

Last reviewed2026-06-11

Anti-neuromuscular Junction acetylcholine receptor antibody positivity

Most people with MG have antibodies against the acetylcholine receptor (AChR) at the nerve-muscle junction. Finding these antibodies in the blood is a main way the diagnosis is confirmed.

Limited evidenceSource: ORPHA:589

Evidence ratingweak

Study designontology_import

Confidence (0-1)0.7

Replicationunreplicated

Supporting sourcesPMID:41338982

Notesplain_language confirmed from PMID:41338982 via curation 2026-06-11.

Last reviewed2026-06-11

Anti-Lrp4 antibody positivity

Some people with MG carry antibodies against a protein called LRP4. This is one of the less common antibody types found in MG.

Limited evidenceSource: ORPHA:589

Evidence ratingweak

Study designontology_import

Confidence (0-1)0.7

Replicationunreplicated

Supporting sourcesPMID:41559594

Notesplain_language confirmed from PMID:41559594 via curation 2026-06-11.

Last reviewed2026-06-11

Dysphagia

Dysphagia means difficulty swallowing. In MG it is common and can raise the risk of food or liquid going into the lungs.

Limited evidenceSource: ORPHA:589

Evidence ratingweak

Study designontology_import

Confidence (0-1)0.7

Replicationunreplicated

Supporting sourcesPMID:41524776

Notesplain_language confirmed from PMID:41524776 via curation 2026-06-11.

Last reviewed2026-06-11

Muscle weakness

Muscle weakness is the core feature of MG. It typically fluctuates, often worsening with activity and improving with rest.

Limited evidenceSource: ORPHA:589

Evidence ratingweak

Study designontology_import

Confidence (0-1)0.7

Replicationunreplicated

Supporting sourcesPMID:41524776

Notesplain_language confirmed from PMID:41524776 via curation 2026-06-11.

Last reviewed2026-06-11

Fatigable weakness of skeletal muscles

The weakness of MG is fatigable, meaning it builds up with use. Muscles for swallowing, speech, and eyelid movement tire and weaken the more they are used.

Limited evidenceSource: ORPHA:589

Evidence ratingweak

Study designontology_import

Confidence (0-1)0.7

Replicationunreplicated

Supporting sourcesPMID:41573440

Notesplain_language confirmed from PMID:41573440 via curation 2026-06-11.

Last reviewed2026-06-11

Single fiber EMG abnormality

Specialized nerve-and-muscle electrical tests, especially single-fiber EMG, are used to confirm MG and tell it apart from similar conditions.

Limited evidenceSource: ORPHA:589

Evidence ratingweak

Study designontology_import

Confidence (0-1)0.7

Replicationunreplicated

Supporting sourcesPMID:41630490

Notesplain_language confirmed from PMID:41630490 via curation 2026-06-11.

Last reviewed2026-06-11

Treatment and management

What the research describes, not a recommendation. Treatment decisions belong with your clinician.

This covers treatments that appear in the published research mapped here. Investigational and experimental therapies are not included, so their absence is a boundary of this map, not a sign they do not exist.

Pyridostigmine

Pyridostigmine is a medicine that relieves MG symptoms. In this patient it rapidly improved drooping eyelids, speech, and swallowing.

Used to help with: Ptosis.

Limited evidenceSource: PMID:41573440

The source text this rests on

“Pyridostigmine was started with rapid improvement in ptosis, speech, and swallowing.”

An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.

Evidence ratingweak

Confidence (0-1)0.7

Replicationunreplicated

Notesconfirmed from PMID:41573440 via curation 2026-06-11

Last reviewed2026-06-11

Zilucoplan

Zilucoplan is a newer targeted medicine for MG. It blocks part of the immune system called complement; in this patient it led to rapid improvement.

Used to help with: Myasthenia gravis.

Limited evidenceSource: PMID:40631640

The source text this rests on

“Zilucoplan (a C5 complement inhibitor) was started, with rapid improvement.”

An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.

Evidence ratingweak

Confidence (0-1)0.7

Replicationunreplicated

Notesconfirmed from PMID:40631640 via curation 2026-06-11

Last reviewed2026-06-11

Thymectomy

Thymectomy is surgery to remove the thymus gland. It is one of the established treatments for MG and is used to help improve long-term outcomes.

Used to help with: Myasthenia gravis.

Limited evidenceSource: PMID:40248578

The source text this rests on

“To improve the prognosis, we need to make available and accessible diagnostic tools and treatments of proven efficacy, such as thymectomy, immunosuppressants, IVIG and PE.”

An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.

Evidence ratingweak

Confidence (0-1)0.7

Replicationunreplicated

Notesconfirmed from PMID:40248578 via curation 2026-06-11

Last reviewed2026-06-11

Plasma exchange

Plasma exchange (plasmapheresis) is a procedure used for severe MG. In this patient it was part of the treatment that led to resolution of symptoms.

Used to help with: Myasthenia gravis.

Limited evidenceSource: PMID:40718168

The source text this rests on

“The patient was treated with plasmapheresis and methylprednisolone pulse therapy, followed by intravenous immunoglobulin therapy, leading to the resolution of his symptoms.”

An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.

Evidence ratingweak

Confidence (0-1)0.7

Replicationunreplicated

Notesconfirmed from PMID:40718168 via curation 2026-06-11

Last reviewed2026-06-11

Intravenous immunoglobulin (IVIG)

Intravenous immunoglobulin (IVIG) is an infusion used for severe MG. In this patient it was part of the treatment that led to resolution of symptoms.

Used to help with: Myasthenia gravis.

Limited evidenceSource: PMID:40718168

The source text this rests on

“The patient was treated with plasmapheresis and methylprednisolone pulse therapy, followed by intravenous immunoglobulin therapy, leading to the resolution of his symptoms.”

An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.

Evidence ratingweak

Confidence (0-1)0.7

Replicationunreplicated

Notesconfirmed from PMID:40718168 via curation 2026-06-11

Last reviewed2026-06-11

Turn this into questions for your doctor

The hardest part is often knowing what to ask. PatientLead Health helps families turn what is on this page into the right questions for their care team.

Prepare for your appointment with PatientLead Health →

How to read the evidence labels

Widely acceptedSpecialists broadly agree on this.

Strong evidenceBacked by solid, repeated research.

Moderate evidenceReasonable evidence, still being confirmed.

Limited evidenceSome evidence, but not yet convincing.

Early evidenceAn early finding that needs more study.

Experts disagreeResearchers actively disagree about this.

Where this comes from

This guide is built from 6 published source(s). Every claim above links back to one of them. Click any source ID to read the original on PubMed.

ORPHA:589 · Orphanet/HPO annotations for Myasthenia gravis

PMID:40248578 · [Treatment and clinical course of autoimmune myasthenia in Burkina Faso].

PMID:40631640 · Unmasking Anti-CASPR2 Syndrome in a Patient Treated for Myasthenia Gravis in the Era of New Treatments.

PMID:40718168 · A Case of Isaacs Syndrome Developed After Thymectomy for Myasthenia Gravis.

PMID:41573440 · Unilateral Ptosis and Bulbar Symptoms as the Initial Presentation of Late-Onset Acetylcholine Receptor Antibody-Positive

PMID:42083560 · Topical pyridostigmine for ocular myasthenia gravis: a translational hypothesis.